News on Pfizer (Ticker: PFE) continually updated from thousands of sources around the net.
2 hrs ago | Pharmaceutical Processing
Pfizer Inc. announced that the company has initiated a multi-center, open-label expanded access program in the United States for the investigational CDK 4/6 inhibitor, palbociclib.
Pfizer Inc. isn't giving up on striking an overseas takeover to cut its tax rate and gain a new pipeline of drugs, even as the potential cost of acquiring AstraZeneca Plc rises.
Children aren't the only segment of our population who can receive vaccinations to help prevent disease.
Bristol-Myers Squibb Company and Pfizer Inc. announced today that they will present 14 abstracts at the ESC Congress 2014, organized by the European Society of Cardiology, to be held August 30 to September 4 in Barcelona, Spain.
At Pfizer PFE +0.35%'s second quarter 2014 earnings call, Ms. Jami Rubin, an industry analyst for Goldman Sachs, posed Pfizer CEO, Ian Read, the following question.
Hawaii-based pharmaceutical company Cardax is partnering with major drug capsule manufacturer Capsugel to mass-produce the anti-inflammatory nutritional supplement called astaxanthin.
Yet, if you've been a shareholder in Pfizer over the past 15 years, and didn't purchase Pfizer stock during the Great Recession, things haven't been so great from a share price perspective.
Spencer Falk, whose marketing expertise was mission-critical to the blockbuster success of Viagra and Celebrex, among other medical brands, today announced that he would lead the commercialization of early cancer detection technology for Senior Scientific, a division of Manhattan Scientifics .
According to GuruFocus list of 52-week lows , these Guru stocks have reached their 52-week lows.
The Alabama Supreme Court has reaffirmed its controversial ruling that brand-name drugmakers can be held liable for injuries caused by drugs produced by generic manufacturers.
AQR Capital Management , managed by Cliff Asness , recently published its 13F filing with the U.S. Securities and Exchange Commission for the second quarter of 2014.
Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer Inc .
Pfizer Inc. today announced it has completed the submission of a New Drug Application to the United States Food and Drug Administration for palbociclib.
This article is a continuation of a monthly series highlighting the top net payout yield stocks that was started back in June 2012 and explained in August 2012 .
Updated: Thu Aug 21, 2014 07:05 am
Copyright © 2014 Topix LLC